{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:34:45Z","timestamp":1773340485799,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.ejphar.2009.02.012","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T09:05:43Z","timestamp":1234775143000},"page":"226-233","source":"Crossref","is-referenced-by-count":12,"title":["Vasoactive intestinal peptide attenuates concanavalin A-mediated liver injury"],"prefix":"10.1016","volume":"607","author":[{"given":"Qingqiong","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dechun","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.02.012_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.imbio.2007.05.006","article-title":"Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production","volume":"212","author":"Allam","year":"2007","journal-title":"Immunobiology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0167-5699(94)90205-4","article-title":"The syntax of immune-neuroendocrine communication","volume":"15","author":"Blalock","year":"1994","journal-title":"Immunology Today"},{"key":"10.1016\/j.ejphar.2009.02.012_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0167-0115(89)90209-7","article-title":"Elevated VIP and endotoxin plasma levels in human gram-negative septic shock","volume":"24","author":"Brandtzaeg","year":"1989","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.ejphar.2009.02.012_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0960-5428(96)00005-8","article-title":"Functional and molecular characterization of VIP receptors and signal transduction in human and rodent immune systems","volume":"6","author":"Calvo","year":"1996","journal-title":"Advances in Neuroimmunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.510300312","article-title":"Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence","volume":"30","author":"Cerny","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annual Review of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.regpep.2006.04.021","article-title":"Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions","volume":"137","author":"Chorny","year":"2006","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.ejphar.2009.02.012_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/365855a0","article-title":"Phosphorylated CREB binds specifically to the nuclear protein CBP","volume":"365","author":"Chrivia","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2009.02.012_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1471-4906(03)00069-3","article-title":"VIP: a very important peptide in T helper differentiation","volume":"24","author":"Delgado","year":"2003","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib10","doi-asserted-by":"crossref","first-page":"31930","DOI":"10.1074\/jbc.274.45.31930","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation","volume":"274","author":"Delgado","year":"1999","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.ejphar.2009.02.012_bib11","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.ejphar.2009.02.012_bib12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6","volume":"162","author":"Delgado","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib13","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib14","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1002\/1521-4141(200011)30:11<3236::AID-IMMU3236>3.0.CO;2-L","article-title":"Anti-inflammatory properties of the type 1 and type 2 vasoactive intestinal peptide receptors: role in lethal endotoxic shock","volume":"30","author":"Delgado","year":"2000","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/87887","article-title":"Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease","volume":"7","author":"Delgado","year":"2001","journal-title":"Nature Medicine"},{"key":"10.1016\/j.ejphar.2009.02.012_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-001-0291-5","article-title":"Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases","volume":"80","author":"Delgado","year":"2002","journal-title":"Journal of Molecular Medicine"},{"key":"10.1016\/j.ejphar.2009.02.012_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/pr.56.2.7","article-title":"The significance of vasoactive intestinal peptide in immunomodulation","volume":"56","author":"Delgado","year":"2004","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.ejphar.2009.02.012_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/08916939908994050","article-title":"Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency","volume":"31","author":"Di Marco","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.ejphar.2009.02.012_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/eji.200535430","article-title":"Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis","volume":"36","author":"Fernandez-Martin","year":"2006","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11481-006-9044-0","article-title":"A novel mechanism for immunosuppression: from neuropeptides to regulatory T cells","volume":"1","author":"Ganea","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib21","first-page":"190","article-title":"Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor","volume":"21","author":"Gantner","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib22","first-page":"103","article-title":"The multifunctional role of the co-activator CBP in transcriptional regulation","volume":"52","author":"Goldman","year":"1997","journal-title":"Recent Progress in Hormone Research"},{"key":"10.1016\/j.ejphar.2009.02.012_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2353\/ajpath.2006.051081","article-title":"Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses","volume":"168","author":"Gonzalez-Rey","year":"2006","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib24","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0196-9781(97)00230-1","article-title":"In vitro properties of a high affinity selective antagonist of the VIP1 receptor","volume":"18","author":"Gourlet","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2009.02.012_bib25","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2174\/092986730611220401163446","article-title":"Pharmaceutical VIP: prospects and problems","volume":"6","author":"Gozes","year":"1999","journal-title":"Current Medicinal Chemistry"},{"key":"10.1016\/j.ejphar.2009.02.012_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2005.12.055","article-title":"Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors","volume":"533","author":"Groneberg","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1172\/JCI0215841","article-title":"Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS","volume":"110","author":"Hong","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.ejphar.2009.02.012_bib28","first-page":"62","article-title":"VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production","volume":"30","author":"Kojima","year":"2005","journal-title":"Pancreas"},{"key":"10.1016\/j.ejphar.2009.02.012_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"Kusters","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0753-3322(99)80096-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"53","author":"McFarlane","year":"1999","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2009.02.012_bib31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0196-9781(00)00309-0","article-title":"Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor","volume":"21","author":"Moreno","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2009.02.012_bib32","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1128\/MCB.15.5.2558","article-title":"Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1","volume":"15","author":"Neish","year":"1995","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib33","first-page":"361","article-title":"Inhibitory effect of vasoactive intestinal polypeptide (VIP) on experimental liver metastasis by murine colon 26-L5 carcinoma cells","volume":"10","author":"Ogasawara","year":"1998","journal-title":"Oncology Research"},{"key":"10.1016\/j.ejphar.2009.02.012_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1067\/msy.2003.189","article-title":"Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge","volume":"134","author":"Ono","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.ejphar.2009.02.012_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-0625.2007.00544.x","article-title":"Plasma concentration of selected neuropeptides in patients suffering from psoriasis","volume":"16","author":"Reich","year":"2007","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.169.3951.1217","article-title":"Polypeptide with broad biological activity: isolation from small intestine","volume":"169","author":"Said","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2009.02.012_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/cyto.2002.1948","article-title":"Cytokine expression in three mouse models of experimental hepatitis","volume":"19","author":"Sass","year":"2002","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2009.02.012_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0300-483X(99)00087-6","article-title":"Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins","volume":"138","author":"Schumann","year":"1999","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib39","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/S0002-9440(10)64804-3","article-title":"Importance of Kupffer cells for T-cell-dependent liver injury in mice","volume":"157","author":"Schumann","year":"2000","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.167.1.514","article-title":"Dissection of the intracellular pathways in hepatocytes suggests a role for Jun kinase and IFN regulatory factor-1 in Con A-induced liver failure","volume":"167","author":"Streetz","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.ejphar.2009.02.012_bib41","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1073\/pnas.040566697","article-title":"Critical contribution of liver natural killer T cells to a murine model of hepatitis","volume":"97","author":"Takeda","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2009.02.012_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.ejphar.2009.02.012_bib43","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3769\/radioisotopes.36.7_355","article-title":"Fundamental and clinical evaluation of vasoactive intestinal peptide (VIP) in pancreatitis by radioimmunoassay kit","volume":"36","author":"Uehara","year":"1987","journal-title":"Radioisotopes"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990900137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T01:07:04Z","timestamp":1684890424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990900137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":43,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S001429990900137X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.02.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}